{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T18:11:32Z","timestamp":1787508692680,"version":"build-2736575974"},"reference-count":32,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008497","name":"Boston Scientific Corporation","doi-asserted-by":"publisher","award":["ISROTH00048"],"award-info":[{"award-number":["ISROTH00048"]}],"id":[{"id":"10.13039\/100008497","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","techvir.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Techniques in Vascular and Interventional Radiology"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1053\/j.tvir.2019.02.008","type":"journal-article","created":{"date-parts":[[2019,2,28]],"date-time":"2019-02-28T02:32:10Z","timestamp":1551321130000},"page":"81-86","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Y90 Clinical Data Update: Cholangiocarcinoma, Neuroendocrine Tumor, Melanoma, and Breast Cancer Metastatic Disease"],"prefix":"10.1053","volume":"22","author":[{"given":"Siddharth A.","family":"Padia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.tvir.2019.02.008_bib0001","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1097\/01.sla.0000251366.62632.d3","article-title":"Cholangiocarcinoma: Thirty-one-year experience with 564 patients at a single institution","volume":"245","author":"DeOliveira","year":"2007","journal-title":"Ann Surg."},{"key":"10.1053\/j.tvir.2019.02.008_bib0002","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.jamcollsurg.2008.10.017","article-title":"Operations for intrahepatic cholangiocarcinoma: Single-institution experience of 158 patients","volume":"208","author":"Lang","year":"2009","journal-title":"J Am Coll Surg."},{"key":"10.1053\/j.tvir.2019.02.008_bib0003","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.jvir.2013.02.031","article-title":"Yttrium-90 radioembolization for intrahepatic cholangiocarcinoma: Safety, response, and survival analysis","volume":"24","author":"Mouli","year":"2013","journal-title":"J Vasc Interv Radiol."},{"key":"10.1053\/j.tvir.2019.02.008_bib0004","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s00270-011-0142-x","article-title":"Transarterial hepatic yttrium-90 radioembolization in patients with unresectable intrahepatic cholangiocarcinoma: Factors associated with prolonged survival","volume":"35","author":"Hoffmann","year":"2012","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1053\/j.tvir.2019.02.008_bib0005","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jvir.2013.10.056","volume":"25","author":"Camacho","year":"2014","journal-title":"J Vasc Interv Radiol"},{"key":"10.1053\/j.tvir.2019.02.008_bib0006","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/bjc.2016.191","article-title":"Yttrium-90 radioembolization for unresectable\/recurrent intrahepatic cholangiocarcinoma: A survival, efficacy and safety study","volume":"115","author":"Mosconi","year":"2016","journal-title":"Br J Cancer"},{"issue":"10","key":"10.1053\/j.tvir.2019.02.008_bib0007","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1007\/s00259-018-3990-7","article-title":"A MAA-based dosimetric study in patients with intrahepatic cholangiocarcinoma treated with a combination of chemotherapy and 90Y-loaded glass microsphere selective internal radiation therapy","volume":"45","author":"Manceau","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.tvir.2019.02.008_bib0008","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s00270-016-1478-z","article-title":"Embolotherapy for neuroendocrine tumor liver metastases: Prognostic factors for hepatic progression-free survival and overall survival","volume":"40","author":"Chen","year":"2017","journal-title":"Cardiovasc Intervent Radiol."},{"key":"10.1053\/j.tvir.2019.02.008_bib0009","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00270-014-0947-5","article-title":"Risk of liver abscess formation in patients with prior biliary intervention following yttrium-90 radioembolization","volume":"38","author":"Cholapranee","year":"2015","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1053\/j.tvir.2019.02.008_bib0010","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.ijrobp.2011.07.041","article-title":"Radioembolization for neuroendocrine liver metastases: Safety, imaging, and long-term outcomes","volume":"83","author":"Memon","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1053\/j.tvir.2019.02.008_bib0011","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/bjs.6931","article-title":"Radioembolization with yttrium microspheres for neuroendocrine tumour liver metastases","volume":"97","author":"Cao","year":"2010","journal-title":"Br J Surg"},{"key":"10.1053\/j.tvir.2019.02.008_bib0012","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1097\/SLA.0b013e3181d3d24a","article-title":"Factors predicting response and survival after yttrium-90 radioembolization of unresectable neuroendocrine tumor liver metastases: A critical appraisal of 48 cases","volume":"251","author":"Saxena","year":"2010","journal-title":"Ann Surg"},{"key":"10.1053\/j.tvir.2019.02.008_bib0013","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1016\/j.jvir.2017.07.008","article-title":"Tumor dose response in yttrium-90 resin microsphere embolization for neuroendocrine liver metastases: A tumor-specific analysis with dose estimation using SPECT-CT","volume":"28","author":"Chansanti","year":"2017","journal-title":"J Vasc Interv Radiol"},{"key":"10.1053\/j.tvir.2019.02.008_bib0014","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1016\/j.jvir.2017.05.011","article-title":"Long-term hepatotoxicity of yttrium-90 radioembolization as treatment of metastatic neuroendocrine tumor to the liver","volume":"28","author":"Su","year":"2017","journal-title":"J Vasc Interv Radiol"},{"key":"10.1053\/j.tvir.2019.02.008_bib0015","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1080\/07357900802620893","article-title":"A first report of radioembolization for hepatic metastases from ocular melanoma","volume":"27","author":"Kennedy","year":"2009","journal-title":"Cancer Invest"},{"key":"10.1053\/j.tvir.2019.02.008_bib0016","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1001\/archopht.123.12.1639","article-title":"Development of metastatic disease after enrollment in the COMS trials for treatment of choroidal melanoma: Collaborative Ocular Melanoma Study Group Report No. 26","volume":"123","author":"Diener-West","year":"2005","journal-title":"Arch Ophthalmol"},{"key":"10.1053\/j.tvir.2019.02.008_bib0017","doi-asserted-by":"crossref","first-page":"468","DOI":"10.2214\/AJR.10.4881","article-title":"Radioembolization as salvage therapy for hepatic metastasis of uveal melanoma: A single-institution experience","volume":"196","author":"Gonsalves","year":"2011","journal-title":"AJR Am J Roentgenol"},{"key":"10.1053\/j.tvir.2019.02.008_bib0018","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/COC.0000000000000109","article-title":"Selective internal yttrium-90 radioembolization therapy (90Y-SIRT) versus best supportive care in patients with unresectable metastatic melanoma to the liver refractory to systemic therapy: Safety and efficacy cohort study","volume":"40","author":"Xing","year":"2017","journal-title":"Am J Clin Oncol"},{"key":"10.1053\/j.tvir.2019.02.008_bib0019","doi-asserted-by":"crossref","first-page":"517","DOI":"10.2967\/jnumed.115.165050","article-title":"Safety, efficacy, and prognostic factors after radioembolization of hepatic metastases from breast cancer: A large single-center experience in 81 patients","volume":"57","author":"Fendler","year":"2016","journal-title":"J Nucl Med"},{"key":"10.1053\/j.tvir.2019.02.008_bib0020","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.jvir.2016.05.028","article-title":"Yttrium-90 radioembolization of advanced, unresectable breast cancer liver metastases-a single-center experience","volume":"27","author":"Pieper","year":"2016","journal-title":"J Vasc Interv Radiol"},{"key":"10.1053\/j.tvir.2019.02.008_bib0021","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1002\/cncr.23818","article-title":"Treatment of unresectable cholangiocarcinoma using yttrium-90 microspheres: Results from a pilot study","volume":"113","author":"Ibrahim","year":"2008","journal-title":"Cancer"},{"key":"10.1053\/j.tvir.2019.02.008_bib0022","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1245\/s10434-009-0777-x","article-title":"Yttrium-90 radiotherapy for unresectable intrahepatic cholangiocarcinoma: A preliminary assessment of this novel treatment option","volume":"17","author":"Saxena","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"10.1053\/j.tvir.2019.02.008_bib0023","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s00432-016-2291-4","article-title":"Resin-based Yttrium-90 microspheres for unresectable and failed first-line chemotherapy intrahepatic cholangiocarcinoma: Preliminary results","volume":"143","author":"Jia","year":"2017","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1053\/j.tvir.2019.02.008_bib0024","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.cct.2016.08.001","article-title":"Neuroendocrine tumor liver metastases treated with yttrium-90 radioembolization","volume":"50","author":"Fan","year":"2016","journal-title":"Contemp Clin Trials"},{"key":"10.1053\/j.tvir.2019.02.008_bib0025","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1002\/cncr.23685","article-title":"Radioembolization with selective internal radiation microspheres for neuroendocrine liver metastases","volume":"113","author":"King","year":"2008","journal-title":"Cancer"},{"key":"10.1053\/j.tvir.2019.02.008_bib0026","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/s00270-011-0248-1","article-title":"Radioembolization of symptomatic, unresectable neuroendocrine hepatic metastases using yttrium-90 microspheres","volume":"35","author":"Paprottka","year":"2012","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1053\/j.tvir.2019.02.008_bib0027","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/COC.0000000000000033","article-title":"Yttrium-90 microsphere brachytherapy for liver metastases from uveal melanoma: Clinical outcomes and the predictive value of fluorodeoxyglucose positron emission tomography","volume":"39","author":"Eldredge-Hindy","year":"2016","journal-title":"Am J Clin Oncol"},{"key":"10.1053\/j.tvir.2019.02.008_bib0028","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/s00270-012-0373-5","article-title":"Radioembolization as locoregional therapy of hepatic metastases in uveal melanoma patients","volume":"36","author":"Klingenstein","year":"2013","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1053\/j.tvir.2019.02.008_bib0029","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/j.jvir.2014.07.007","article-title":"Yttrium-90 radioembolization stops progression of targeted breast cancer liver metastases after failed chemotherapy","volume":"25","author":"Gordon","year":"2014","journal-title":"J Vasc Interv Radiol"},{"key":"10.1053\/j.tvir.2019.02.008_bib0030","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1245\/s10434-013-3436-1","article-title":"Yttrium-90 radioembolization for unresectable, chemoresistant breast cancer liver metastases: A large single-center experience of 40 patients","volume":"21","author":"Saxena","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1053\/j.tvir.2019.02.008_bib0031","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/s00330-012-2556-5","article-title":"Radioembolisation with (90)Y-labelled resin microspheres in the treatment of liver metastasis from breast cancer","volume":"23","author":"Cianni","year":"2013","journal-title":"Eur Radiol"},{"key":"10.1053\/j.tvir.2019.02.008_bib0032","doi-asserted-by":"crossref","first-page":"371","DOI":"10.2967\/jnumed.111.096230","article-title":"18F-FDG PET\/CT predicts survival after radioembolization of hepatic metastases from breast cancer","volume":"53","author":"Haug","year":"2012","journal-title":"J Nucl Med"}],"container-title":["Techniques in Vascular and Interventional Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089251619300150?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089251619300150?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T17:54:23Z","timestamp":1761069263000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089251619300150"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S1089251619300150"],"URL":"https:\/\/doi.org\/10.1053\/j.tvir.2019.02.008","relation":{},"ISSN":["1089-2516"],"issn-type":[{"value":"1089-2516","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Y90 Clinical Data Update: Cholangiocarcinoma, Neuroendocrine Tumor, Melanoma, and Breast Cancer Metastatic Disease","name":"articletitle","label":"Article Title"},{"value":"Techniques in Vascular and Interventional Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.tvir.2019.02.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}